Amira is a pharmacist who gained her PhD in the in-field detection of New Psychoactive Substance (NPS). Amira is the MPharm Programme Director at Swansea University Medical School and a Senior Fellow of the Higher Education Academy. She is the Scheduled Drugs Lead of the RPS (Royal Pharmaceutical Society) Science and Research Committee, a committee member of JPAG (Joint Pharmaceutical Analysis Group), RPS London North West, Research Strategy Implementation Group for Wales (RSIG) and a member of the RPS Medicines, Ethics and Practice advisory board. Amira’s research interests focus on enhancing the in-field detection of NPS, training and education of healthcare professionals on NPS and developing harm reduction interventions including establishing Drug Checking Services.
Apr 26, 2024 01:37 am UTC| Insights & Views Health
Vaping is now more common than cigarette smoking among young people, according to a new report coordinated by the University of Glasgow and commissioned by the World Health Organization. This echoes research that has...
Over-the-counter opioids: does Britain have a codeine problem?
Jun 15, 2023 05:39 am UTC| Insights & Views
Earlier this year, the NHS announced that it had cut opioid prescriptions by almost half a million in four years. But opioids arent just available on prescription in the UK. They can be bought over the counter at...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Biden administration tells employers to stop shackling workers with ‘noncompete agreements’
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects